Dear customers, all orders for hardcopy versions will be sent on 6th January 2026, we wish you a Merry Christmas and a Happy New Year

Log inSign up
LANGUAGE en
Menu
STOREHelp centerContactsDelivery chargesABOUT US News
SEARCH
0
Total price
0 EUR
PRICES include / exclude VAT
>BSI Standards >11 HEALTH CARE TECHNOLOGY>11.040 Medical equipment>11.040.40 Implants for surgery, prosthetics and orthotics>BS ISO 13019:2018 Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis
immediate downloadReleased: 2018-06-11
BS ISO 13019:2018 Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

BS ISO 13019:2018

Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

Format
Availability
Price and currency
English Secure PDF
Immediate download
Printable - You are authorized to print 1 copy
259.84 EUR
English Hardcopy
In stock
259.84 EUR
Standard number:BS ISO 13019:2018
Pages:24
Released:2018-06-11
ISBN:978 0 580 89425 1
Status:Standard
DESCRIPTION

BS ISO 13019:2018


This standard BS ISO 13019:2018 Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis is classified in these ICS categories:
  • 11.040.40 Implants for surgery, prosthetics and orthotics

This document specifies test methods for the quantification of sulfated glycosaminoglycans (sGAG), one of the major extracellular matrix components in articular, meniscal, and elastic cartilages, and tissue-engineered cartilage constructs.


Print